Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT01057342 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel
DRUG: vadimezan

Sponsor

Swiss Cancer Institute